Response of pulmonary tuberculoma to anti-tuberculosis treatment

Y. S. Shim, S. K. Han, H. S. Lee, C. T. Lee, Y. W. Kim, J. J. Yim (Seoul, South Korea)

Source: Annual Congress 2003 - Management of tuberculosis
Session: Management of tuberculosis
Session type: Thematic Poster Session
Number: 3249
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. S. Shim, S. K. Han, H. S. Lee, C. T. Lee, Y. W. Kim, J. J. Yim (Seoul, South Korea). Response of pulmonary tuberculoma to anti-tuberculosis treatment. Eur Respir J 2003; 22: Suppl. 45, 3249

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Response of pulmonary tuberculomas to anti-tuberculous treatment
Source: Eur Respir J 2004; 23: 452-455
Year: 2004



Side-effect in the treatment of pulmonary tuberculosis by first-line drugs
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Therapeutic pneumothorax in the treatment of cavitary lung TB: a renaissance of collapsotherapy
Source: Eur Respir J 2004; 24: Suppl. 48, 650s
Year: 2004

Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Surgical treatment of first found pulmonary tuberculosis at ineffectiveness of DOTS therapy
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011

Response to empirical anti-tuberculosis treatment in patients with sputum smear-negative pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 845s
Year: 2006

Surgical treatment of pulmonary tuberculosis
Source: Eur Respir Monogr 2013; 61: 20-36
Year: 2013


Effectiveness of complex treatment of bilateral destructive pulmonary XDR-tuberculosis
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021


Surgery as a treatment for pulmonary tuberculosis
Source: Eur Respir Monogr 2018; 82: 228-233
Year: 2018


Choroidal granuloma presenting during anti-tuberculous chemotherapy administration
Source: Eur Respir J 2006; 28: Suppl. 50, 26s
Year: 2006

Surgical treatment of combination of tuberculosis and pulmonary echinococcosis
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011

Treatment results of new cases of sputum-positive pulmonary tuberculosis with standard chemotherapeutical regimen
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002

Surgical treatment of first-found destructive pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Efficacy of a standard chemotherapy regimen in the management of sputum-positive pulmonary TB relapses
Source: Eur Respir J 2003; 22: Suppl. 45, 41s
Year: 2003

Isoniazid resistance is associated with delayed culture conversion during anti-tuberculosis treatment among patients with pulmonary tuberculosis
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



Effectiveness of thoracoplasty at disseminated drug-resistant fibrous-cavernous pulmonary tuberculosis
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010

Diagnosis and treatment delay in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003

Monitoring of antituberculous drugs adverse events during the treatment of multidrug-resistant pulmonary tuberculosis
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011


The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016

Unusual presentation of pulmonary nocardiosis as pyopneumothorax in a patient under corticotherapy
Source: International Congress 2019 – Interstitial lung diseases?
Year: 2019